Article ID Journal Published Year Pages File Type
6015183 Epilepsy Research 2016 7 Pages PDF
Abstract
This study demonstrated a long-term benefit of rufinamide as adjunctive therapy for Japanese patients with LGS. Exacerbation of seizures and decreased appetite/weight loss should be monitored carefully.
Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , , , ,